FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989931815> ?p ?o ?g. }

• W1989931815 endingPage "416" @default.
• W1989931815 startingPage "409" @default.
• W1989931815 abstract "Summary Background This trial evaluated the safety, tolerability and maximum tolerated dose (MTD) of afatinib, a novel ErbB Family Blocker. Methods In this open-label, dose-escalation Phase I study, afatinib was administered continuously, orally, once-daily for 28 days to patients with advanced or metastatic solid tumors. Dose escalation was performed in a 3 + 3 design, with a starting dose of 10 mg/day (d); doses were doubled for each successive cohort until the MTD was defined. The MTD cohort was expanded to a total of 19 patients. Incidence and severity of adverse events (AEs), antitumor activity and pharmacokinetics were assessed. Results Thirty patients received at least one dose of afatinib. Twenty-nine patients were evaluable for response. Dose-limiting toxicities (DLTs) consisting of Grade 3 diarrhea were observed in two out of three patients treated at 60 mg/d. The MTD was determined at 40 mg/d. The most frequent treatment-related AEs were diarrhea and mucosal inflammation reported in 76.7 % and 43.3 % of patients respectively. Five patients had stable disease with a median progression-free survival of 111 days. No objective responses occurred. Pharmacokinetic data showed no deviation from dose-proportionality and steady-state was reached on Day 8 at the latest. Conclusions Afatinib was well tolerated with manageable side effects when administered once-daily, continuously at a dose of 40 mg." @default.
• W1989931815 created "2016-06-24" @default.
• W1989931815 creator A5009812253 @default.
• W1989931815 creator A5011277587 @default.
• W1989931815 creator A5012095437 @default.
• W1989931815 creator A5031782506 @default.
• W1989931815 creator A5044081105 @default.
• W1989931815 creator A5069690249 @default.
• W1989931815 creator A5075801763 @default.
• W1989931815 creator A5079907189 @default.
• W1989931815 date "2012-12-15" @default.
• W1989931815 modified "2023-09-26" @default.
• W1989931815 title "A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors" @default.
• W1989931815 cites W1819148429 @default.
• W1989931815 cites W1877511630 @default.
• W1989931815 cites W1964321121 @default.
• W1989931815 cites W1968626722 @default.
• W1989931815 cites W1974903851 @default.
• W1989931815 cites W2012784647 @default.
• W1989931815 cites W2046138183 @default.
• W1989931815 cites W2048092750 @default.
• W1989931815 cites W2063391304 @default.
• W1989931815 cites W2069526613 @default.
• W1989931815 cites W2088145034 @default.
• W1989931815 cites W2088634026 @default.
• W1989931815 cites W2095618958 @default.
• W1989931815 cites W2110444464 @default.
• W1989931815 cites W2114095518 @default.
• W1989931815 cites W2121831273 @default.
• W1989931815 cites W2129360604 @default.
• W1989931815 cites W2130616229 @default.
• W1989931815 cites W2132157071 @default.
• W1989931815 cites W2135836172 @default.
• W1989931815 cites W2138297714 @default.
• W1989931815 cites W2139248078 @default.
• W1989931815 cites W2140334822 @default.
• W1989931815 cites W2142661339 @default.
• W1989931815 cites W2142752401 @default.
• W1989931815 cites W2147304472 @default.
• W1989931815 cites W2152905269 @default.
• W1989931815 cites W2153156618 @default.
• W1989931815 cites W2157824687 @default.
• W1989931815 cites W2163252214 @default.
• W1989931815 cites W2166084034 @default.
• W1989931815 cites W2167368130 @default.
• W1989931815 cites W2169332099 @default.
• W1989931815 cites W4229525614 @default.
• W1989931815 cites W4378195240 @default.
• W1989931815 doi "https://doi.org/10.1007/s10637-012-9904-9" @default.
• W1989931815 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3589633" @default.
• W1989931815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23242861" @default.
• W1989931815 hasPublicationYear "2012" @default.
• W1989931815 type Work @default.
• W1989931815 sameAs 1989931815 @default.
• W1989931815 citedByCount "34" @default.
• W1989931815 countsByYear W19899318152013 @default.
• W1989931815 countsByYear W19899318152014 @default.
• W1989931815 countsByYear W19899318152015 @default.
• W1989931815 countsByYear W19899318152016 @default.
• W1989931815 countsByYear W19899318152017 @default.
• W1989931815 countsByYear W19899318152018 @default.
• W1989931815 countsByYear W19899318152019 @default.
• W1989931815 countsByYear W19899318152023 @default.
• W1989931815 crossrefType "journal-article" @default.
• W1989931815 hasAuthorship W1989931815A5009812253 @default.
• W1989931815 hasAuthorship W1989931815A5011277587 @default.
• W1989931815 hasAuthorship W1989931815A5012095437 @default.
• W1989931815 hasAuthorship W1989931815A5031782506 @default.
• W1989931815 hasAuthorship W1989931815A5044081105 @default.
• W1989931815 hasAuthorship W1989931815A5069690249 @default.
• W1989931815 hasAuthorship W1989931815A5075801763 @default.
• W1989931815 hasAuthorship W1989931815A5079907189 @default.
• W1989931815 hasBestOaLocation W19899318151 @default.
• W1989931815 hasConcept C112705442 @default.
• W1989931815 hasConcept C121608353 @default.
• W1989931815 hasConcept C126322002 @default.
• W1989931815 hasConcept C197934379 @default.
• W1989931815 hasConcept C2778087573 @default.
• W1989931815 hasConcept C2778375690 @default.
• W1989931815 hasConcept C2778570526 @default.
• W1989931815 hasConcept C2779438470 @default.
• W1989931815 hasConcept C2779802037 @default.
• W1989931815 hasConcept C2780586478 @default.
• W1989931815 hasConcept C71924100 @default.
• W1989931815 hasConcept C72563966 @default.
• W1989931815 hasConcept C90924648 @default.
• W1989931815 hasConcept C98274493 @default.
• W1989931815 hasConceptScore W1989931815C112705442 @default.
• W1989931815 hasConceptScore W1989931815C121608353 @default.
• W1989931815 hasConceptScore W1989931815C126322002 @default.
• W1989931815 hasConceptScore W1989931815C197934379 @default.
• W1989931815 hasConceptScore W1989931815C2778087573 @default.
• W1989931815 hasConceptScore W1989931815C2778375690 @default.
• W1989931815 hasConceptScore W1989931815C2778570526 @default.
• W1989931815 hasConceptScore W1989931815C2779438470 @default.
• W1989931815 hasConceptScore W1989931815C2779802037 @default.
• W1989931815 hasConceptScore W1989931815C2780586478 @default.
• W1989931815 hasConceptScore W1989931815C71924100 @default.

• next